While time constraints and regulatory requirements become an increasing burden in the pharmaceutical industry, the PhUSE Annual Conference provides a global platform for discussion around the challenges. Focusing on time and efficiency in drug development, the conference encourages attendees to share ideas and experience on data standards, trial design, programming techniques, automated processes, and supporting softwares.
“A sweet spot for Formedix, I am excited to join the discussions on speed, efficiency and automation in clinical trials,”said Formedix CEO Mark Wheeldon.
Data Management, Biostatistics and Statistical Programming professionals will meet in Barcelona to network and join the fast track to approval conversation. With 16 years’ experience of CDISC standards and FDA submissions, Formedix is well placed to contribute to the discussion.
Wheeldon continues, “As an organization we advocate the use of data standards upfront in studies. Our solutions automate trial processes and improve the quality of submission deliverables, with some demonstrable time and cost savings.”
Companies using Formedix solutions have benefited from a 68% reduction in study setup time and 100% automation of EDC builds through integrations with 7 of the leading EDC providers. Formedix promotes content reuse across clinical trials.
Watch our “Streamlining the Route to Submissions” webinar
where we focus on reducing the time to submission and increasing the quality of deliverables.